DarioHealth Corp’s Shares Reel: -20.30% Quarterly Revenue Decline Amid 25.02M Market Cap

The stock price for DarioHealth Corp (DRIO) currently stands at $0.55. The stock experienced a substantial increase in the last session, hitting $4.0 after starting at $0.55. The stock’s lowest price was $0.6 before closing at $0.43.

The market performance of DarioHealth Corp’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $1.55 on 01/07/25, while the lowest value for the same duration was $0.38 on 08/12/25.

52-week price history of DRIO Stock

Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. DarioHealth Corp’s current trading price is -64.52% away from its 52-week high, while its distance from the 52-week low is 44.74%. The stock’s price range during the 52-week period has remained between $0.38 and $1.55. In the Healthcare sector, the company’s shares saw a trading volume of around 0.65 million for the day, which was evidently higher than the average daily volume of 0.17 million over the past three months.

Market Capitalization and Financial Performance: An In-Depth Look

DarioHealth Corp (DRIO) has experienced a quarterly decline of -20.30% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 25.02M and boasts a workforce of 202 employees.

A Closer Look at Analysts’ Ratings for DarioHealth Corp

As of right now, 3 analysts are rating DarioHealth Corp as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.6591, with a change in price of -0.0730. Similarly, DarioHealth Corp recorded 198,196 in trading volume during the last 100 days, posting a change of -11.72%.

Examining DRIO’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for DRIO stands at 0.49. Similarly, the long-term debt-to-equity ratio is also 0.49.

DRIO Stock Stochastic Average

DarioHealth Corp’s raw stochastic average for the past 50 days is presently 47.22%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 56.29%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 30.03% and 22.62%, respectively.

DRIO Stock Price Performance Analysis

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. This year’s metric has recorded a Price decrease of -42.33%. However, over the past six months, we’ve seen a stronger performance of -21.08%. The price of DRIO leaped by -21.43% over the last 30 days. And in the last five days, it has surged by 26.20%.

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.